Clinical Trial Update: Study of the Efficacy and Safety of SCH 619734 in Subjects With Chronic Cough From an Unknown Cause (Study P04888) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating SCH 619734 for chronic cough of unknown origin has completed, assessing its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• SCH 619734

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Cough | Phase 2 | Status: COMPLETED